Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online April 24, 2007
Diabetes 56:1999-2007, 2007
DOI: 10.2337/db06-1766
© 2007 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
db06-1766v1
56/8/1999    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Doyle, M. J.
Right arrow Articles by Sussel, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Doyle, M. J.
Right arrow Articles by Sussel, L.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Nkx2.2 Regulates ß-Cell Function in the Mature Islet

Michelle J. Doyle, and Lori Sussel

From the Program in Molecular Biology, Department of Biochemistry and Genetics, University of Colorado Health Sciences Center, Aurora, Colorado

Address correspondence and reprint requests to Lori Sussel, Biochemistry and Molecular Genetics, Mail Stop 8101, 12801 E. 17th Ave., Room 10101, P.O. Box 6511, Aurora, CO 80045. E-mail: lori.sussel{at}uchsc.edu

Nkx2.2 is a homeodomain transcription factor that is critical for pancreatic endocrine cell specification and differentiation in the developing mouse embryo. The purpose of this study was to determine whether Nkx2.2 is also required for the maintenance and function of the mature ß-cell in the postnatal islet. We have demonstrated previously that a repressor derivative of Nkx2.2 can functionally substitute for endogenous Nkx2.2 to fully restore {alpha}- and immature ß-cells in the embryonic islet; however, Nkx2.2 activator functions appear to be required to form a functional ß-cell. In this study, we have created transgenic mouse lines to express the Nkx2.2-repressor derivative in the mature ß-cell in the presence of endogenous Nkx2.2. The transgenic mice were assessed for ß-cell function, overall islet structure, and expression of ß-cell–specific markers. Using this transgenic approach, we have determined that the Nkx2.2-repressor derivative disrupts endogenous Nkx2.2 expression in adult mice and causes downregulation of the mature ß-cell factors, MafA and Glut2. Consistently, the Nkx2.2-repressor mice display reduced insulin gene expression and pancreatic insulin content and impaired insulin secretion. At weaning, the male Nkx2.2-repressor mice are overtly diabetic and all Nkx2.2-repressor transgenic mice exhibit glucose intolerance. Furthermore, the loss of ß-cell function in the Nkx2.2-repressor transgenic mice is associated with disrupted islet architecture. These studies indicate a previously undiscovered role for Nkx2.2 in the maintenance of mature ß-cell function and the formation of normal islet structure.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2007 by the American Diabetes Association.